PharmaCompass – Grow Your Pharma Business Digitally

NEWS LIBRARY

Genentech to Present New Data of Its Alzheimer’s Program at the AAIC

BIOSPACE

FDA Lays Out New Pathways for Nonprescription Drugs

Michael Mezher

RAPS

Johnson & Johnson Told to Pay $4.7 Billion in Baby Powder Lawsuit

Tiffany Hsu

NYTIMES

Recent Approvals

20 Jul 2018

Santen Oy's Verkazia (ciclosporin) Receives Approval in Europe

20 Jul 2018

Mylan Labs Ltd.’s Generic Busulfan Receives Approval in the US

20 Jul 2018

West-Ward Pharms’ Generic Imatinib Mesylate Receives Approval in the US

Compliance Alerts

18 Jul 2018

FDA Issues Form 483 to Hetero Drugs Ltd. Unit 1

18 Jul 2018

Yangzhou Holyshine Industrial On FDA Import Alert List

18 Jul 2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan Tablets

ENQUIRIES FOR APIs

Enquiry// Loxoprofen sodium (500 kg) needed in Korea

20 Jul 2018

A distribution company based in the Republic of Korea is looking for suppliers of Loxoprofen sodium API (500 kg). Suppliers must support the product with COA and GMP certificate.

Comments

Enquiry// Colesevelam API (25 kg) needed in Australia

20 Jul 2018

A leading compounding company based in Australia is looking for suppliers of Colesevelam API (25 kg).

Comments

Enquiry// Doxycycline Monohydrate API needed in Costa Rica

20 Jul 2018

A company in Costa Rica is looking for suppliers/manufacturers of Doxycycline Monohydrate API.

Comments

View APIs Requests

ENQUIRIES FOR FINISHED FORMULATIONS

Enquiry// Looking at In-licensing opportunity for Sorafenib tablets for the US market

12 Jul 2018

A Leading Indian Pharmaceutical company is looking at In-licensing opportunity for Sorafenib tablets for the US market.

Comments

Enquiry// Tamsulosin 0.4 mcg capsules needed for the UK market

11 Jul 2018

A leading pharmaceutical wholesaler serving the pharmaceutical and healthcare industries in the UK and throughout the world is looking for suppliers/manufacturers of Tamsulosin 0.4 mcg capsules. The quantity required is 700,000 packs PA.

Comments

Enquiry// EU Suppliers of Semisodium Valproate Delayed release tablets (250 mg and 500 mg) needed in Mexico

04 Jul 2018

A fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain is looking for EU suppliers of Semisodium Valproate Delayed-release tablets (250 mg and 500 mg) for their Mexican subsidiary. The manufacturer must be PIC/s approved.

Comments

View Finished Formulations Requests